Massive newborn brain study launches in china

NCT ID NCT02544100

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study aims to create a large database of medical information and biological samples from 2,000 newborns with brain conditions like encephalopathy. Researchers will collect blood, urine, and spinal fluid samples, along with genetic data, to better understand and monitor brain injury. The goal is to use this big data to predict brain damage and guide treatment in the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to better ways to monitor and predict brain injury in newborns, and provide a rich data resource for future research.

What could go wrong

This is an observational study, not a treatment trial. It collects data and samples, so it won't directly help participants. Results may take years to impact care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEONATAL ENCEPHALOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Children Hospital of Fudan University

    RECRUITING

    Shanghai, Shanghai Municipality, 201102, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••